[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

IMARC Group: Market Research Reports

The International Market Analysis Research and Consulting Group (IMARC Group) has been keeping the top position in terms of provision consultancy services on management strategy and market for above 5 years.

IMARC Group serves customers from diverse industry areas in various regions of the globe by identifying their premium-value biz opps, dealing with their most burning issues, and converting their businesses. The company bears its clients a hand in improving decision-making and strategy-planning processes as well as in moving their business to a higher level.

The reports published by IMARC offer precise information on a slew of industries such as pharmaceutical, high-technology, advanced materials, food and beverage, biotechnology, nanotechnology, tourism and travel and a far more. The reports include detailed market analyses, overviews and forecasts, reviews of the economic and technological developments, profiles of the dominant companies, market/product assessments, etc. IMARC’s research approach unites deep insight into the market dynamics together with strong cooperation with each level of the client organization.

Publications found: 10,783
Sort by:

Cerebral Palsy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major cerebral palsy markets reached a value of US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.5 Billion by 2034, exhibiting a growth rate (CAGR) of 2.53% d...

May 2024 128 pages

Cervical Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major cervical cancer markets reached a value of US$ 405.6 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 583.4 Million by 2034, exhibiting a growth rate (CAGR) of 3....

May 2024 137 pages

Cervical Dysplasia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major cervical dysplasia markets are expected to exhibit a CAGR of 3.2% during 2024-2034. The cervical dysplasia market has been comprehensively analyzed in IMARC's new report titled 'Cervical D...

May 2024 138 pages

Cervical Dystonia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major cervical dystonia markets reached a value of US$ 148.2 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 270.0 Million by 2034, exhibiting a growth rate (CAGR) of...

May 2024 138 pages

Cervix Lesion Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major cervix lesion markets are expected to exhibit a CAGR of 3.92% during 2024-2034. The cervix lesion market has been comprehensively analyzed in IMARC's new report titled 'Cervix Lesion Marke...

May 2024 128 pages

Chagas Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Chagas disease markets are expected to exhibit a CAGR of 3.19% during 2024-2034. The Chagas disease market has been comprehensively analyzed in IMARC's new report titled 'Chagas Disease Ma...

May 2024 135 pages

Charcot-Marie-Tooth Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Charcot-Marie-Tooth disease markets reached a value of US$ 814.5 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 8,995.2 Million by 2034, exhibiting a growth rat...

May 2024 139 pages

Chemotherapy-Induced Anemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast ?2024-2034?

US$ 6,499.00

The 7 major chemotherapy-induced anemia markets are expected to exhibit a CAGR of 7.2% during 2024-2034. The chemotherapy-induced anemia market has been comprehensively analyzed in IMARC's new report...

May 2024 137 pages

Chemotherapy-Induced Diarrhea Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major chemotherapy-induced diarrhea markets reached a value of US$ 84.5 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 153.1 Million by 2034, exhibiting a growth rate...

May 2024 130 pages

Chemotherapy-Induced Hearing Loss Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major chemotherapy-induced hearing loss markets reached a value of US$ 9.2 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 13.3 Million by 2034, exhibiting a growth ra...

May 2024 136 pages

Chemotherapy-Induced Neutropenia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major chemotherapy-induced neutropenia markets reached a value of US$ 371.2 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 455.7 Million by 2034, exhibiting a growth...

May 2024 138 pages

Chemotherapy Induced Pain Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major chemotherapy induced pain markets are expected to exhibit a CAGR of 4.15% during 2024-2034 The chemotherapy induced pain market has been comprehensively analyzed in IMARC's new report titl...

May 2024 128 pages

Chemotherapy-Induced Peripheral Neuropathy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major chemotherapy-induced peripheral neuropathy markets are expected to exhibit a CAGR of 4.44% during 2024-2034. The chemotherapy-induced peripheral neuropathy market has been comprehensively...

May 2024 129 pages

Chiari Malformation Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Chiari malformation markets are expected to exhibit a CAGR of 6.43% during 2024-2034. The Chiari malformation market has been comprehensively analyzed in IMARC's new report titled 'Chiari...

May 2024 134 pages

Chickenpox Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major chickenpox markets are expected to exhibit a CAGR of 3.9% during 2024-2034. The chickenpox market has been comprehensively analyzed in IMARC's new report titled 'Chickenpox Market: Epidemi...

May 2024 128 pages

Choroideremia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major choroideremia markets are expected to exhibit a CAGR of 4.22% during 2024-2034. The choroideremia market has been comprehensively analyzed in IMARC's new report titled 'Choroideremia Marke...

May 2024 133 pages

Chronic Bronchitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major chronic bronchitis markets are expected to exhibit a CAGR of 2.69% during 2024-2034. The chronic bronchitis market has been comprehensively analyzed in IMARC's new report titled 'Chronic B...

May 2024 135 pages

Chronic Constipation Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major chronic constipation markets are expected to exhibit a CAGR of 4.64% during 2024-2034. The chronic constipation market has been comprehensively analyzed in IMARC's new report titled 'Chron...

May 2024 132 pages

Chronic Cough Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major chronic cough markets reached a value of US$ 4.8 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 8.5 Billion by 2034, exhibiting a growth rate (CAGR) of 5.38% du...

May 2024 130 pages

Chronic Gout Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major chronic gout markets are expected to exhibit a CAGR of 11.12% during 2024-2034. The chronic gout market has been comprehensively analyzed in IMARC's new report titled 'Chronic Gout Market:...

May 2024 129 pages

Chronic Hand Eczema Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major chronic hand eczema markets reached a value of US$ 12.6 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 26.8 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 138 pages

Chronic Heart Failure Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major chronic heart failure markets reached a value of US$ 6.6 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 18.5 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 130 pages

Chronic Hepatitis B Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major chronic hepatitis B markets reached a value of US$ 2,709.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3,379.3 Million by 2034, exhibiting a growth rate (CAG...

May 2024 140 pages

Chronic Idiopathic Constipation Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major chronic idiopathic constipation markets reached a value of US$ 6.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 10.7 Billion by 2034, exhibiting a growth rate...

May 2024 134 pages

Chronic Kidney Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major chronic kidney disease markets reached a value of US$ 5.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 11.0 Billion by 2034, exhibiting a growth rate (CAGR) o...

May 2024 129 pages

Chronic Lower Back Pain Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major chronic lower back pain markets reached a value of US$ 6.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 10.0 Billion by 2034, exhibiting a growth rate (CAGR)...

May 2024 130 pages

Chronic Lymphocytic Leukemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major chronic lymphocytic leukemia markets reached a value of US$ 8.9 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 14.6 Billion by 2034, exhibiting a growth rate (C...

May 2024 133 pages

Chronic Myeloid Leukemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major chronic myeloid leukemia markets reached a value of US$ 5.5 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 8.5 Billion by 2034, exhibiting a growth rate (CAGR)...

May 2024 128 pages

Chronic Obstructive Pulmonary Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major chronic obstructive pulmonary disease markets reached a value of US$ 13,464.0 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 18,551.6 Million by 2034, exhibitin...

May 2024 133 pages

Chronic Pain Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast ?2024-2034?

US$ 6,499.00

The 7 major chronic pain markets reached a value of US$ 21.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 28.9 Billion by 2034, exhibiting a growth rate (CAGR) of 2.9% du...

May 2024 140 pages

Chronic Pancreatitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major chronic pancreatitis markets reached a value of US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.4 Billion by 2034, exhibiting a growth rate (CAGR) of 3...

May 2024 138 pages

Chronic Refractory Cough Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major chronic refractory cough markets reached a value of US$ 9.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 14.1 Billion by 2034, exhibiting a growth rate (CAGR)...

May 2024 132 pages

Chronic Sialorrhea Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major chronic sialorrhea markets reached a value of US$ 1.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.2 Billion by 2034, exhibiting a growth rate (CAGR) of 4.1...

May 2024 137 pages

Chronic Urticaria Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast ?2024-2034?

US$ 6,499.00

The 7 major chronic urticaria markets reached a value of US$ 14.0 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 32.4 Million by 2034, exhibiting a growth rate (CAGR) of 7....

May 2024 137 pages

Chronic Venous Insufficiency Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major chronic venous insufficiency markets are expected to exhibit a CAGR of 4.18% during 2024-2034. The chronic venous insufficiency market has been comprehensively analyzed in IMARC's new repo...

May 2024 131 pages

Chronic Wounds Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major chronic wounds markets reached a value of US$ 5.5 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 7.6 Billion by 2034, exhibiting a growth rate (CAGR) of 2.96% d...

May 2024 131 pages

Churg-Strauss Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Churg-Strauss syndrome markets are expected to exhibit a CAGR of 4.51% during 2024-2034. The Churg-Strauss syndrome market has been comprehensively analyzed in IMARC's new report titled 'C...

May 2024 136 pages

Clostridium Difficile Infection Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Clostridium difficile infection markets reached a value of US$ 9.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 14.9 Billion by 2034, exhibiting a growth rate...

May 2024 136 pages

Cluster Headache Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major cluster headache markets reached a value of US$ 812.8 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,124.6 Million by 2034, exhibiting a growth rate (CAGR) of...

May 2024 131 pages

CNS Lymphoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major CNS lymphoma markets are expected to exhibit a CAGR of 3.99% during 2024-2034. The CNS lymphoma market has been comprehensively analyzed in IMARC's new report titled 'CNS Lymphoma Market:...

May 2024 138 pages

Coagulation Protein Disorders Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major coagulation protein disorders markets are expected to exhibit a CAGR of 7.6% during 2024-2034. The coagulation protein disorders market has been comprehensively analyzed in IMARC's new rep...

May 2024 137 pages

Coccidioidomycosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major coccidioidomycosis markets reached a value of US$ 132.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 209.5 Million by 2034, exhibiting a growth rate (CAGR) of...

May 2024 135 pages

Cold Agglutinin Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major cold agglutinin disease markets are expected to exhibit a CAGR of 16.2% during 2024-2034. The cold agglutinin disease market has been comprehensively analyzed in IMARC's new report titled...

May 2024 136 pages

Colorectal Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major colorectal cancer markets reached a value of US$ 13.6 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 17.3 Billion by 2034, exhibiting a growth rate (CAGR) of 2....

May 2024 140 pages

Common Cold Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major common cold markets are expected to exhibit a CAGR of 4.37% during 2024-2034. The common cold market has been comprehensively analyzed in IMARC's new report titled 'Common Cold Market: Epi...

May 2024 138 pages

Common Warts Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major common warts markets reached a value of US$ 761.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,056.6 Million by 2034, exhibiting a growth rate (CAGR) of 3.0...

May 2024 137 pages

Compartment Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major compartment syndrome markets reached a value of US$ 367.3 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 707.7 Million by 2034, exhibiting a growth rate (CAGR)...

May 2024 134 pages

Complement 3 Glomerulopathy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major complement 3 glomerulopathy markets reached a value of US$ 9.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 11.8 Billion by 2034, exhibiting a growth rate (CA...

May 2024 131 pages

Complicated Urinary Tract Infections (cUTIs) Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major complicated urinary tract infections (cUTIs) markets are expected to exhibit a CAGR of 5.6% during 2024-2034. The complicated urinary tract infections (cUTIs) market has been comprehensive...

May 2024 136 pages

Concussions Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major concussions markets reached a value of US$ 792.2 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,069.3 Million by 2034, exhibiting a growth rate (CAGR) of 2.76...

May 2024 128 pages

Filters

Search

Categories

2,591
8
343
112
107
17
231
64
26
7
12
3
1
1
243
125
111
3
323
240
20
8
2
86
2
1
1
5
4
567
353
1
227
2
262
326
2
2
7
5
5
5
4
4
3
2
2
2
2
2
1
3
4
2
1
1
2
2
5
20
5
1
1
1
168
12
1
2
1
1
3
8
1,641
1,337
909
28
8
7
6
5
5
5
4
4
3
3
3
3
1
1
1
1
1
1
1

Publishers

10,783

Regions

1
10,741
1
3
5
3
1
25
3

Price

Date

Pages

Offers